ECS Botanics Holdings Ltd (ASX:ECS)
Australia
· Delayed Price · Currency is AUD 0.0120
-0.0010 (-7.69%)
Apr 28, 2025, 1:26 PM AEST
ECS Botanics Holdings Revenue
ECS Botanics Holdings had revenue of 9.73M AUD in the half year ending December 31, 2024, with 43.07% growth. This brings the company's revenue in the last twelve months to 18.48M, down -6.99% year-over-year. In the fiscal year ending June 30, 2024, ECS Botanics Holdings had annual revenue of 20.03M with 30.16% growth.
Revenue (ttm)
18.48M
Revenue Growth
-6.99%
P/S Ratio
0.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.85M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |